World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
124
Citations
51032
World Ranking
3244
National Ranking
1788

Overview

Michael J. Zelefsky is affiliated with Memorial Sloan Kettering Cancer Center in the United States. Their research primarily focuses on medical and clinical studies related to oncology and radiotherapy, with a significant emphasis on prostate cancer diagnosis and treatment as well as advanced radiotherapy techniques.

Their work is published extensively in several prominent journals. Frequent publication venues include: International Journal of Radiation Oncology*Biology*Physics, Brachytherapy, Radiotherapy and Oncology, Advances in Radiation Oncology, and Journal of Clinical Oncology.

Michael J. Zelefsky's research spans a range of related fields. Their main field of study is Medicine, with specific subfields including: Pulmonary and Respiratory Medicine, Radiation, Radiology, Nuclear Medicine and Imaging, Surgery, and Oncology.

The primary topics covered in their research include:

  • Prostate Cancer Diagnosis and Treatment
  • Advanced Radiotherapy Techniques
  • Prostate Cancer Treatment and Research
  • Radiation Dose and Imaging
  • Urinary Bladder and Prostate Research
  • Colorectal Cancer Surgical Treatments
  • Health Systems, Economic Evaluations, Quality of Life

They have collaborated frequently with several coauthors, including:

  • Marisa Kollmeier
  • Daniel Gorovets
  • Sean M. McBride
  • Antonio L. Damato
  • Zhigang Zhang

Among their recent published papers are:

  • Phase 3 Multi-Center, Prospective, Randomized Trial Comparing Single-Dose 24 Gy Radiation Therapy to a 3-Fraction SBRT Regimen in the Treatment of Oligometastatic Cancer, 2021, International Journal of Radiation Oncology*Biology*Physics
  • Clinical implementation of deep learning contour autosegmentation for prostate radiotherapy, 2021, Radiotherapy and Oncology
  • Development and Validation of a Clinical Prognostic Stage Group System for Nonmetastatic Prostate Cancer Using Disease-Specific Mortality Results From the International Staging Collaboration for Cancer of the Prostate, 2020, JAMA Oncology
  • Pathogenic ATM Mutations in Cancer and a Genetic Basis for Radiotherapeutic Efficacy, 2020, JNCI Journal of the National Cancer Institute
  • Low dose rate brachytherapy for primary treatment of localized prostate cancer: A systemic review and executive summary of an evidence-based consensus statement, 2021, Brachytherapy

Best Publications

  • A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score.

    Jonathan I. Epstein;Michael J. Zelefsky;Daniel D. Sjoberg;Joel B. Nelson

  • Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer.

    Michael J. Zelefsky;Steven A. Leibel;Paul Gaudin;Gerald J. Kutcher

  • Predicting the Outcome of Salvage Radiation Therapy for Recurrent Prostate Cancer After Radical Prostatectomy

    Andrew J. Stephenson;Peter T. Scardino;Michael W. Kattan;Thomas M. Pisansky

  • High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients

    Michael J Zelefsky;Zvi Fuks;Margie Hunt;Yoshiya Yamada

  • HIGH DOSE RADIATION DELIVERED BY INTENSITY MODULATED CONFORMAL RADIOTHERAPY IMPROVES THE OUTCOME OF LOCALIZED PROSTATE CANCER

    Michael J. Zelefsky;Zvi Fuks;Margie Hunt;Henry J. Lee

  • Incidence of Late Rectal and Urinary Toxicities After Three-Dimensional Conformal Radiotherapy and Intensity-Modulated Radiotherapy for Localized Prostate Cancer

    Michael J. Zelefsky;Emily J. Levin;Margie Hunt;Yoshiya Yamada

  • Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer.

    Michael J Zelefsky;Zvi Fuks;Laura Happersett;Henry J Lee

  • Salvage Radiotherapy for Recurrent Prostate Cancer After Radical Prostatectomy

    Andrew J. Stephenson;Shahrokh F. Shariat;Michael J. Zelefsky;Michael W. Kattan

  • Fluoroscopically Guided Interventional Procedures: A Review of Radiation Effects on Patients’ Skin and Hair

    Stephen Balter;John W. Hopewell;Donald L. Miller;Louis K. Wagner

  • Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group.

    Peter Grimm;Ignace Billiet;David Bostwick;Adam P Dicker

  • High-Dose, Single-Fraction Image-Guided Intensity-Modulated Radiotherapy for Metastatic Spinal Lesions

    Yoshiya Yamada;Mark H. Bilsky;D. Michael Lovelock;Ennapadam S. Venkatraman

  • Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: Update of the Memorial Sloan-Kettering experience

    Suzanne L. Wolden;William C. Chen;David G. Pfister;Dennis H. Kraus

  • Long-Term Outcome of High Dose Intensity Modulated Radiation Therapy for Patients With Clinically Localized Prostate Cancer

    Michael J. Zelefsky;Heather Chan;Margie Hunt;Yoshiya Yamada

  • Improved Clinical Outcomes With High-Dose Image Guided Radiotherapy Compared With Non-IGRT for the Treatment of Clinically Localized Prostate Cancer

    Michael J. Zelefsky;Marisa Kollmeier;Brett Cox;Anthony Fidaleo

  • Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation.

    Michael J. Zelefsky;Deborah A. Kuban;Larry B. Levy;Louis Potters

  • Androgen receptor signaling regulates DNA repair in prostate cancers

    William R. Polkinghorn;Joel S. Parker;Man X. Lee;Elizabeth M. Kass

  • American Brachytherapy Society consensus guidelines for transrectal ultrasound-guided permanent prostate brachytherapy

    Brian J. Davis;Eric M. Horwitz;W. Robert Lee;Juanita M. Crook

  • Late rectal bleeding after conformal radiotherapy of prostate cancer (II): volume effects and dose–volume histograms

    Andrew Jackson;Mark W Skwarchuk;Michael J Zelefsky;Didier M Cowen

  • Late rectal toxicity after conformal radiotherapy of prostate cancer (I): multivariate analysis and dose-response.

    Mark W Skwarchuk;Andrew Jackson;Michael J Zelefsky;Ennapadam S Venkatraman

  • Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy

    Peter R. Carroll

Frequent Co-Authors

Zvi Fuks
Zvi Fuks Memorial Sloan Kettering Cancer Center
Steven A. Leibel
Steven A. Leibel Memorial Sloan Kettering Cancer Center
Yoshiya Yamada
Yoshiya Yamada Memorial Sloan Kettering Cancer Center
C. Clifton Ling
C. Clifton Ling Memorial Sloan Kettering Cancer Center
Dennis H. Kraus
Dennis H. Kraus Northwell Health
David G. Pfister
David G. Pfister Memorial Sloan Kettering Cancer Center
Jatin P. Shah
Jatin P. Shah Memorial Sloan Kettering Cancer Center
Louis B. Harrison
Louis B. Harrison Moffitt Cancer Center
Daniel E. Spratt
Daniel E. Spratt University of Michigan–Ann Arbor
Nancy Y. Lee
Nancy Y. Lee Memorial Sloan Kettering Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering a future in medicine but want more flexible or specialized study options, online healthcare degrees offer excellent alternatives. Many aspiring nurses now pursue advanced practice credentials through the best online bsn to dnp programs, which allow nurses to achieve a doctoral level in nursing while balancing work and personal commitments.

For those interested in pharmacy, pharm d online programs provide a pathway to becoming a Doctor of Pharmacy without the need to relocate or sacrifice work experience. These programs blend clinical knowledge and managerial skills, preparing students for the evolving healthcare landscape.

Healthcare relies on modern data management, and him programs (Health Information Management) are quickly becoming essential for those looking to work at the intersection of health, data, and administration.

Additionally, medical billing and coding online courses are ideal for anyone interested in the administrative side of medicine. These credentials can open doors to remote work and entry-level roles, offering a fast track into the healthcare industry.

Best Scientists Citing Michael J. Zelefsky

Trending Scientists

Recently Published Articles